Skip to content
OpenCapital
Get started

Agilent Technologies A Proceeds from exercises of stock options and other stock issuances

Proceeds from exercises of stock options and other stock issuances at other companies

Revvity logo
RevvityRVTY
——
WAT
Waters CorporationWAT
——
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
——
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——

Other financials

Income statement

See full
Revenue$1.8B+10.0%
Gross profit$990.0M+14.3%
Operating income$399.0M+33.0%
Net income$339.0M+57.7%
EPS (diluted)$1.20+60.0%

Balance sheet

See full
Cash & equivalents$1.8B+21.5%
Total debt$3.5B-3.9%
Total equity$7.1B+16.1%
Total assets$13.1B+7.5%

Cash flow

See full
Operating cash flow$277.0M+25.3%
CapEx$76.0M-33.3%
Free cash flow$201.0M+87.9%

Valuation

See full
Market cap$37.52B+8.8%
Enterprise value$39.25B+7.0%
P/E26.5×-3.0×
P/S5.2×0.0×

Profitability

See full
Gross margin52.7%-0.6pp
Operating margin21.5%+0.1pp
Net margin19.6%+2.0pp
FCF margin15%-2.9pp

Returns & leverage

See full
Return on equity21.3%+2.4pp
Debt / equity0.5×-0.1×
Current ratio2.1×0.0×

Where this comes from

Reported directly by Agilent Technologies in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Agilent Technologies’s 10-Q, filed June 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilent Technologies's proceeds from exercises of stock options and other stock issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilent Technologies's proceeds from exercises of stock options and other stock issuances?
Agilent Technologies (A) reported proceeds from exercises of stock options and other stock issuances of $1M in Q1 2026.
How has Agilent Technologies's proceeds from exercises of stock options and other stock issuances changed year-over-year?
Agilent Technologies's proceeds from exercises of stock options and other stock issuances decreased by 0.0% year-over-year, from $1M to $1M.
What is the long-term trend for Agilent Technologies's proceeds from exercises of stock options and other stock issuances?
Over 4 years (2021 to 2025), Agilent Technologies's proceeds from exercises of stock options and other stock issuances has grown at a 7.0% compound annual growth rate (CAGR), from $55M to $72M.